Related Experiment Videos
Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: a preliminary report
M S Piver1, J Malfetano, T R Baker
1Department of Gynecologic Oncology, Roswell Park Memorial Institute, Buffalo, New York 14263.
Gynecologic Oncology
|October 1, 1989
Abstract:
Thirty stage I patients with invasive ovarian adenocarcinoma were treated with 6 months of adjuvant induction cisplatin and monthly cisplatin, adriamycin, and cyclophosphamide. To date, 97% (29) are alive with no evidence of disease and normal CA-125 levels and 93% (28) are alive progression free with a median follow-up of 34 months (13-56).